296 related articles for article (PubMed ID: 22610174)
1. Na+/Ca2+ exchanger-1 protects against systolic failure in the Akitains2 model of diabetic cardiomyopathy via a CXCR4/NF-κB pathway.
LaRocca TJ; Fabris F; Chen J; Benhayon D; Zhang S; McCollum L; Schecter AD; Cheung JY; Sobie EA; Hajjar RJ; Lebeche D
Am J Physiol Heart Circ Physiol; 2012 Aug; 303(3):H353-67. PubMed ID: 22610174
[TBL] [Abstract][Full Text] [Related]
2. Type 1 diabetic cardiomyopathy in the Akita (Ins2WT/C96Y) mouse model is characterized by lipotoxicity and diastolic dysfunction with preserved systolic function.
Basu R; Oudit GY; Wang X; Zhang L; Ussher JR; Lopaschuk GD; Kassiri Z
Am J Physiol Heart Circ Physiol; 2009 Dec; 297(6):H2096-108. PubMed ID: 19801494
[TBL] [Abstract][Full Text] [Related]
3. Induced overexpression of Na+/Ca2+ exchanger transgene: altered myocyte contractility, [Ca2+]i transients, SR Ca2+ contents, and action potential duration.
Wang J; Chan TO; Zhang XQ; Gao E; Song J; Koch WJ; Feldman AM; Cheung JY
Am J Physiol Heart Circ Physiol; 2009 Aug; 297(2):H590-601. PubMed ID: 19525383
[TBL] [Abstract][Full Text] [Related]
4. Induced overexpression of phospholemman S68E mutant improves cardiac contractility and mortality after ischemia-reperfusion.
Wang J; Song J; Gao E; Zhang XQ; Gu T; Yu D; Koch WJ; Feldman AM; Cheung JY
Am J Physiol Heart Circ Physiol; 2014 Apr; 306(7):H1066-77. PubMed ID: 24486513
[TBL] [Abstract][Full Text] [Related]
5. Comparison of speckle-tracking echocardiography with invasive hemodynamics for the detection of characteristic cardiac dysfunction in type-1 and type-2 diabetic rat models.
Mátyás C; Kovács A; Németh BT; Oláh A; Braun S; Tokodi M; Barta BA; Benke K; Ruppert M; Lakatos BK; Merkely B; Radovits T
Cardiovasc Diabetol; 2018 Jan; 17(1):13. PubMed ID: 29338775
[TBL] [Abstract][Full Text] [Related]
6. Induced overexpression of Na(+)/Ca(2+) exchanger does not aggravate myocardial dysfunction induced by transverse aortic constriction.
Wang J; Gao E; Chan TO; Zhang XQ; Song J; Shang X; Koch WJ; Feldman AM; Cheung JY
J Card Fail; 2013 Jan; 19(1):60-70. PubMed ID: 23273595
[TBL] [Abstract][Full Text] [Related]
7. NOD1, a new player in cardiac function and calcium handling.
Delgado C; Ruiz-Hurtado G; Gómez-Hurtado N; González-Ramos S; Rueda A; Benito G; Prieto P; Zaragoza C; Delicado EG; Pérez-Sen R; Miras-Portugal MT; Núñez G; Boscá L; Fernández-Velasco M
Cardiovasc Res; 2015 Jun; 106(3):375-86. PubMed ID: 25824149
[TBL] [Abstract][Full Text] [Related]
8. Cardiac-specific suppression of NF-κB signaling prevents diabetic cardiomyopathy via inhibition of the renin-angiotensin system.
Thomas CM; Yong QC; Rosa RM; Seqqat R; Gopal S; Casarini DE; Jones WK; Gupta S; Baker KM; Kumar R
Am J Physiol Heart Circ Physiol; 2014 Oct; 307(7):H1036-45. PubMed ID: 25085967
[TBL] [Abstract][Full Text] [Related]
9. Serine 68 of phospholemman is critical in modulation of contractility, [Ca2+]i transients, and Na+/Ca2+ exchange in adult rat cardiac myocytes.
Song J; Zhang XQ; Ahlers BA; Carl LL; Wang J; Rothblum LI; Stahl RC; Mounsey JP; Tucker AL; Moorman JR; Cheung JY
Am J Physiol Heart Circ Physiol; 2005 May; 288(5):H2342-54. PubMed ID: 15653756
[TBL] [Abstract][Full Text] [Related]
10. TNF-α down-regulates sarcoplasmic reticulum Ca²⁺ ATPase expression and leads to left ventricular diastolic dysfunction through binding of NF-κB to promoter response element.
Tsai CT; Wu CK; Lee JK; Chang SN; Kuo YM; Wang YC; Lai LP; Chiang FT; Hwang JJ; Lin JL
Cardiovasc Res; 2015 Mar; 105(3):318-29. PubMed ID: 25712896
[TBL] [Abstract][Full Text] [Related]
11. Sodium-glucose cotransporter 2 inhibitor Dapagliflozin attenuates diabetic cardiomyopathy.
Arow M; Waldman M; Yadin D; Nudelman V; Shainberg A; Abraham NG; Freimark D; Kornowski R; Aravot D; Hochhauser E; Arad M
Cardiovasc Diabetol; 2020 Jan; 19(1):7. PubMed ID: 31924211
[TBL] [Abstract][Full Text] [Related]
12. MiR-21 protected against diabetic cardiomyopathy induced diastolic dysfunction by targeting gelsolin.
Dai B; Li H; Fan J; Zhao Y; Yin Z; Nie X; Wang DW; Chen C
Cardiovasc Diabetol; 2018 Sep; 17(1):123. PubMed ID: 30180843
[TBL] [Abstract][Full Text] [Related]
13. Regulation of cardiac myocyte contractility by phospholemman: Na+/Ca2+ exchange versus Na+ -K+ -ATPase.
Song J; Zhang XQ; Wang J; Cheskis E; Chan TO; Feldman AM; Tucker AL; Cheung JY
Am J Physiol Heart Circ Physiol; 2008 Oct; 295(4):H1615-25. PubMed ID: 18708446
[TBL] [Abstract][Full Text] [Related]
14. Calcium Homeostasis in Ventricular Myocytes of Diabetic Cardiomyopathy.
Al Kury LT
J Diabetes Res; 2020; 2020():1942086. PubMed ID: 33274235
[TBL] [Abstract][Full Text] [Related]
15. Induced NCX1 overexpression attenuates pressure overload-induced pathological cardiac remodelling.
Ujihara Y; Iwasaki K; Takatsu S; Hashimoto K; Naruse K; Mohri S; Katanosaka Y
Cardiovasc Res; 2016 Sep; 111(4):348-61. PubMed ID: 27229460
[TBL] [Abstract][Full Text] [Related]
16. Chronic administration of the nitroxyl donor 1-nitrosocyclo hexyl acetate limits left ventricular diastolic dysfunction in a mouse model of diabetes mellitus in vivo.
Cao N; Wong YG; Rosli S; Kiriazis H; Huynh K; Qin C; Du XJ; Kemp-Harper BK; Ritchie RH
Circ Heart Fail; 2015 May; 8(3):572-81. PubMed ID: 25737497
[TBL] [Abstract][Full Text] [Related]
17. NF-κB-Dependent Upregulation of NCX1 Induced by Angiotensin II Contributes to Calcium Influx in Rat Aortic Smooth Muscle Cells.
Liu B; Yang L; Zhang B; Kuang C; Huang S; Guo R
Can J Cardiol; 2016 Nov; 32(11):1356.e11-1356.e20. PubMed ID: 27378593
[TBL] [Abstract][Full Text] [Related]
18. MiR-20a-5p overexpression prevented diabetic cardiomyopathy via inhibition of cardiomyocyte apoptosis, hypertrophy, fibrosis and JNK/NF-κB signalling pathway.
Liu X; Guo B; Zhang W; Ma B; Li Y
J Biochem; 2021 Oct; 170(3):349-362. PubMed ID: 33837411
[TBL] [Abstract][Full Text] [Related]
19. Adenovirally delivered shRNA strongly inhibits Na+-Ca2+ exchanger expression but does not prevent contraction of neonatal cardiomyocytes.
Hurtado C; Ander BP; Maddaford TG; Lukas A; Hryshko LV; Pierce GN
J Mol Cell Cardiol; 2005 Apr; 38(4):647-54. PubMed ID: 15808841
[TBL] [Abstract][Full Text] [Related]
20. Confirmation of the Cardioprotective Effect of MitoGamide in the Diabetic Heart.
Park M; Nishimura T; Baeza-Garza CD; Caldwell ST; Pun PBL; Prag HA; Young T; Sauchanka O; Logan A; Forkink M; Gruszczyk AV; Prime TA; Arndt S; Naudi A; Pamplona R; Coughlan MT; Tate M; Ritchie RH; Caicci F; Kaludercic N; Di Lisa F; Smith RAJ; Hartley RC; Murphy MP; Krieg T
Cardiovasc Drugs Ther; 2020 Dec; 34(6):823-834. PubMed ID: 32979176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
